Skip to the page

Data / Form D filings / Assurtek Surgical, Inc.

Assurtek Surgical, Inc.: Form D filings

Assurtek Surgical, Inc., a biotechnology company in Lebanon, NH, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on March 25, 2025, reports $370,000 sold of a $370,000 offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
16 CAVENDISH COURT, Lebanon, NH, 03766
Phone
(541) 399-3643
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2045855

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 25, 2025Amendment$370,000$370,0008Nov 8, 2024sec.gov
Mar 25, 2025Amendment$370,000$370,0008Nov 8, 2024sec.gov
Nov 25, 2024New notice$350,000$270,000$80,0002Nov 8, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan HalterExecutive Officer, Director
Michael SalinExecutive Officer, Director
David LopezExecutive Officer, Director
Alicia EverittExecutive Officer, Director
Robert SegalDirector

Every Form D from the week of Mar 24, 2025 · All recent filings in New Hampshire · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Assurtek Surgical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.